Previous close | 0.8500 |
Open | N/A |
Bid | 0.2000 |
Ask | 0.6500 |
Strike | 55.00 |
Expiry date | 2024-11-15 |
Day's range | 0.8500 - 0.8500 |
Contract range | N/A |
Volume | |
Open interest | 5 |
Baxter (BAX) reports better-than-expected first-quarter earnings and sales. BAX's quarterly results reflect solid demand for a range of its medically essential products.
Robust Operational Performance Drives Growth Amidst Strategic Transformations
Baxter (BAX) delivered earnings and revenue surprises of 6.56% and 1.20%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?